Price T Rowe Associates Inc Oyster Point Pharma, Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$10.17 - $18.96 $173,174 - $322,850
-17,028 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$11.67 - $18.07 $11,226 - $17,383
-962 Reduced 5.35%
17,028 $202,000
Q2 2021

Aug 16, 2021
SELL
$16.25 - $21.51 $452,188 - $598,558
-27,827 Reduced 60.74%
17,990 $309,000
Q1 2021

May 17, 2021
BUY
$17.92 - $25.86 $821,040 - $1.18 Million
45,817 New
45,817 $838,000

Others Institutions Holding OYST

# of Institutions
4
Shares Held
19K
Call Options Held
0
Put Options Held
0
View Full List

About Oyster Point Pharma, Inc.

OYST Quotes by TradingView
  • Ticker OYST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,831,500
  • Description
  • Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...
More about OYST
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email